Zymeworks Bc Inc.
Clinical trials sponsored by Zymeworks Bc Inc., explained in plain language.
-
Experimental drug targets tough liver cancers in first human trial
Disease control Recruiting nowThis is the first study in humans testing whether ZW251, a new targeted cancer drug, is safe and can help people with advanced liver cancer and other solid tumors. Researchers will give the drug to about 100 participants to find the right dose and see if it shrinks tumors. The ma…
Phase: PHASE1 • Sponsor: Zymeworks BC Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New cancer drug enters human testing for Tough-to-Treat tumors
Disease control Recruiting nowThis is a first-in-human study to test the safety and early signs of effectiveness of a new cancer drug called ZW191. It is for adults with advanced solid tumors, such as ovarian, endometrial, and non-small cell lung cancers, that have spread or returned. The main goal is to find…
Phase: PHASE1 • Sponsor: Zymeworks BC Inc. • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC